Medicare Enrolled

Dr. Dilip Kachare, M.D.

Adolescent Medicine · Utica, NY
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
2037 GENESEE ST, Utica, NY 13501
3157341086
In practice since 2005 (20 years)
NPI: 1477549939 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Kachare from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Kachare? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Kachare

Dr. Dilip Kachare is an adolescent medicine specialist in Utica, NY, with 20 years of NPI registration. Based on federal Medicare data, Dr. Kachare performed 1,080 Medicare services across 471 unique beneficiaries.

Between the years covered by Open Payments, Dr. Kachare received a total of $3,588 from 27 pharmaceutical and/or device companies across 127 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in adolescent medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Kachare is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice ▲ Top 17% volume in NY $3,588 industry payments

Medicare Practice Summary

Medicare Utilization ↗
1,080
Medicare services
Top 17% in NY for adolescent medicine
471
Unique beneficiaries
$69
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~54 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Hospital follow-up visit, moderate complexity
Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service.
482 $60 $113
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
190 $84 $150
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
165 $60 $105
Initial hospital admission, moderate complexity
Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter.
109 $99 $204
Hospital discharge management, 30+ min
This service covers the care provided by a physician or qualified healthcare professional on the day a patient is discharged from the hospital. It requires more than 30 minutes of total time spent on the day of discharge.
63 $87 $179
Flu vaccine administration
This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient.
27 $29 $30
Flu vaccine, quadrivalent
A flu shot containing four strains of the influenza virus to help prevent seasonal influenza infection.
24 $74 $75
Hospital follow-up visit, low complexity
Follow-up hospital visit for an established patient with straightforward or low-level medical decision making. The visit requires at least 25 minutes of time spent on the day of service.
20 $38 $61
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$3,588
Total received (2018-2024)
Avg $513/year across 7 years
Top 5% in NY for adolescent medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
27
Companies
127
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$3,588 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$561
2023
$418
2022
$436
2021
$523
2020
$248
2019
$783
2018
$617

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Phathom Pharmaceuticals, Inc.
$237
Bayer Healthcare Pharmaceuticals Inc.
$144
Gilead Sciences, Inc.
$135
Dexcom, Inc.
$31
AstraZeneca Pharmaceuticals LP
$14
Top 3 companies account for 91.9% of 2024 payments
All-time payments by company (2018-2024) ›
Novo Nordisk Inc
$662
Janssen Pharmaceuticals, Inc
$349
Merck Sharp & Dohme LLC
$305
Phathom Pharmaceuticals, Inc.
$237
Novartis Pharmaceuticals Corporation
$225
Bayer Healthcare Pharmaceuticals Inc.
$197
E.R. Squibb & Sons, L.L.C.
$194
Merck Sharp & Dohme Corporation
$178
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$169
GlaxoSmithKline, LLC.
$164
Gilead Sciences, Inc.
$135
Biohaven Pharmaceuticals, Inc.
$125
AstraZeneca Pharmaceuticals LP
$116
Amarin Pharma Inc.
$113
Boehringer Ingelheim Pharmaceuticals, Inc.
$95
Abbott Laboratories
$57
PFIZER INC.
$56
Lilly USA, LLC
$38
Relypsa, Inc.
$37
Dexcom, Inc.
$31
Biohaven Pharmaceutical Holding Company Ltd.
$26
SANOFI-AVENTIS U.S. LLC
$15
Ultragenyx Pharmaceutical Inc.
$15
Lexicon Pharmaceuticals, Inc.
$15
SK Life Science, Inc.
$11
Bayer HealthCare Pharmaceuticals Inc.
$11
Allergan, Inc.
$11
Top 3 companies account for 36.7% of all-time payments
Associated products mentioned in payments ›
ANORO · BREO · Biktarvy · DIFICID · Dexcom G6 Transmitter · ELIQUIS · EMGALITY · ENTRESTO · FARXIGA · FREESTYLE LIBRE 2 · INVOKANA · Inpefa · JARDIANCE · Kerendia · NURTEC ODT · Ozempic · PAXLOVID · RYBELSUS · Rybelsus · SOLIQUA 100/33 · STIOLTO RESPIMAT · Saxenda · TRADJENTA · TRELEGY ELLIPTA · TRULICITY · Tresiba · VERQUVO · VOQUEZNA · VRAYLAR · Vascepa · Veltassa · Victoza · XARELTO · XIFAXAN
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 5% for adolescent medicine in NY.

Looking for an adolescent medicine specialist in Utica?
Compare adolescent medicines in the Utica area by procedure volume, costs, and industry payment transparency.
Browse adolescent medicines nearby

Geographic Context

Adolescent medicines within 10 mi
2
Per 100K population
0.9
County median income
$68,819
Nearest hospital
MOHAWK VALLEY PSYCHIATRIC CENTER
5.5 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Kachare is a clinical cardiology specialist, with above-average Medicare volume (top 17% in NY), with low-engagement industry engagement in the top 5% of NY peers, with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Kachare experienced with hospital follow-up visit, moderate complexity?
Based on Medicare claims data, Dr. Kachare performed 482 hospital follow-up visit, moderate complexity services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Kachare receive payments from pharmaceutical companies?
Yes. Dr. Kachare received a total of $3,588 from 27 companies across 127 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Kachare's costs compare to other adolescent medicines in Utica?
Dr. Kachare's average Medicare payment per service is $69. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Kachare) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →